Clinicopathological characteristics and prognostic analysis of oral squamous cell carcinoma with parotid lymph node metastasis

doi:10.19438/j.cjoms.2022.01.005

Abstract

Abstract: PURPOSE: To investigate the clinical regularity of oral squamous cell carcinoma(OSCC) with parotid lymph node metastasis and its influence on prognosis. METHODS: A retrospective analysis of the clinicopathological data of 60 oral squamous cell carcinoma patients with or without parotid lymph node metastasis admitted to Shanghai Ninth People's Hospital of Shanghai Jiao Tong University School of Medicine from January 2003 to December 2017 was conducted. SPSS 23.0 software package was used for data analysis. RESULTS: Primary tumor T stage(P=0.022) and cervical lymph node status(N stage, P=0.008) were closely related to parotid lymph node metastasis. Parotid metastatic lymph nodes were mostly located in the lower pole of the superficial parotid gland and prone to extracellular invasion(P<0.05). Parotid gland lymph node metastasis is closely related to the prognosis of oral squamous cell carcinoma(P=0.0004), and the 5-year survival rate of gingival squamous cell carcinoma with parotid lymph node metastasis was significantly higher than that of tongue squamous cell carcinoma(P=0.0427). CONCLUSIONS: Parotid lymph node metastasis is a poor prognostic factor for oral squamous cell carcinoma. Higher T and N stages are two important factors that promote LN metastasis to parotid gland in OSCC patients.

Key words: Oral squamous cell carcinoma, Parotid lymph node, Metastasis, Prognosis

CLC Number:

R739.8

LI Xing, XU Fei-hu, YANG Yun-bo, HAN Nan-nan, RUAN Min. Clinicopathological characteristics and prognostic analysis of oral squamous cell carcinoma with parotid lymph node metastasis[J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(1): 28-31.

References

[1] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69(1): 7-34.
[2] 张志愿. 口腔颌面外科学[M]. 第7版. 北京: 人民卫生出版社, 2012: 320-350.
[3] Pantvaidya G, Rao K, D'Cruz A. Management of the neck in oral cancers[J]. Oral Oncol, 2020, 100: 104476.
[4] Arimoto S, Hasegawa T, Takeda D, et al.Lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma[J]. Anticancer Res, 2018, 38(11): 6157-6162.
[5] Mendenhall NP, Million RR, Cassisi NJ.Parotid area lymph node metastases from carcinoma of the skin[J]. Int J Radiat Oncol Biol Phys, 1985, 11(4): 707-714.
[6] Audet N, Palme CE, Gullane PJ, et al.Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome[J]. Head Neck, 2004, 26(8):727-732.
[7] Rodrigo JP, Grilli G, Shah JP, et al.Selective neck dissection in surgically treated head and neck squamous cell carcinoma patients with a clinically positive neck: systematic review[J]. Eur J Surg Oncol, 2018, 44(4): 395-403.
[8] Zhou X, Temam S, Oh M, et al.Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma[J]. Neoplasia, 2006, 8(11): 925-932.
[9] Pollaers K, Hinton-Bayre A, Friedland PL, et al.AJCC 8th Edition oral cavity squamous cell carcinoma staging-is it an improvement on the AJCC 7th Edition?[J]. Oral Oncol, 2018, 82: 23-28.
[10] Stenner M, Molls C, Luers JC, et al.Occurrence of lymph node metastasis in early-stage parotid gland cancer[J]. Eur Arch Otorhinolaryngol, 2012, 269(2): 643-648.
[11] Samra S, Sawh-Martinez R, Tom L, et al.A targeted approach to sentinel lymph node biopsies in the parotid region for head and neck melanomas[J]. Ann Plast Surg, 2012, 69(4): 415-417.
[12] Loree TR, Tomljanovich PI, Cheney RT, et al.Intraparotid sentinel lymph node biopsy for head and neck melanoma[J]. Laryngoscope, 2006, 116(8):1461-1464.
[13] Myers LL, Ahn C.Cutaneous squamous cell carcinoma metastasis to the parotid region lymph nodes[J]. Laryngoscope, 2019, 129(7): 1579-1586.

[1]	LIU Jiang-long, JIA Fang, WANG Xiao-rong, REYILAI Abudukeremu, WUERGULI Alifu, MAIMAITITUXUN Tuerdi. Diagnostic value of contrast-enhanced ultrasound in cervical lymph node metastasis from oral and maxillofacial squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 168-174.
[2]	REZIWANGULI·Yasen, MAIREPATI·Maiming, LI Chen-xi, GONG Zhong-cheng. Research progress in the role and mechanism of Porphyromonas gingivalis in promoting oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 186-190.
[3]	LAN Rong, RUAN Min, HAN Nan-nan, WANG Feng. Peri-implant squamous cell carcinoma appeared after implant-restoration in the left mandible: a case report [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 203-205.
[4]	SU Zi-shang, CUI Wen-li, ZHANG Meng-yun, YAO Zhi-tao. Relationship between cervical lymph node characteristics and prognosis in oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 41-48.
[5]	LIU Heng, DUAN Xiao-feng. Research progress of ferritinophagy and related genes FTH1 and NCOA4 in oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 87-91.
[6]	YANG Hui-li, WANG Yu-fan, WANG Feng, SHEN Yue-hong, YANG Hong-yu. Comprehensive co-expression analysis revealed NLRP1 as a prognostic immune-associated gene in head and neck squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(5): 429-436.
[7]	JI Ping-ping, LI Li, WU Yi-fan, HOU Li-li. Effect of transcutaneous electrical acupoint stimulation on myelosuppression in patients with oral squamous cell carcinoma after induction chemotherapy [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(5): 455-460.
[8]	XU Gang, SONG Qi-yi, JIANG Wei-dong, LIU Jing-xiu. Expression and clinical significance of aquaporin 3 in oral mucosal epithelial dysplasia and oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(5): 478-482.
[9]	ZHAO Xiao-mei, XIA Rong-hui, ZHONG Lai-ping, ZHU Dong-wang, ZHANG Zhi-yuan. Effect of Nrf2 on TPF induced chemotherapy for oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(4): 366-370.
[10]	YANG Song, WANG Ning, ZHAO Shu-chao, LI Heng-yong, GE Sheng-you, ZHOU Kai, SONG Kai, SHANG Wei, FENG Yuan-yong. Expression and clinical significance of chemerin in oral squamous cell carcinoma patients combined with type 2 diabetes [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(4): 390-395.
[11]	ZHANG Yi-yi, YANG Yue-yi, JU Wu-tong, ZHONG Lai-ping. Neoadjuvant immunotarget therapy in patients with locally advanced oral squamous cell carcinoma: report of 2 cases and literature review [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(4): 413-416.
[12]	WEI Dong-liang, LI Zhi, JU Hou-yu, WU Yun-teng, GUO Wei, REN Guo-xin. Mechanism of EGFR-targeted drugs for pain relief in oral cancer [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(3): 219-224.
[13]	FU Hong-hai, QIU Na-na, SUN Le-gang, WANG Fang. Case report of parotid, submandibular lymph node metastasis of ocular sebaceous gland carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(3): 307-309.
[14]	SUN Da-wei, ZHANG Yun, ZHU Yong. Effect of shRNA interference Rce1gene expression on the radiosensitivity of oral squamous cell carcinoma cells [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(2): 123-128.
[15]	NUERMANGULI·Yasen, DUOLIKUN·Wufuer, BAIERNA·Wushuoer, YAN Guang-peng. The relationship between serum IL-6, IL-17, TNF-α, IFN-γ levels, clinical characteristics of60patients with oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(2): 141-145.